HLEMX | RNWHX | HLEMX / RNWHX | |
Total Expense Ratio | 1.14 | 0.72 | 158% |
Annual Report Gross Expense Ratio | 1.14 | 0.72 | 158% |
Fund Existence | 27 years | 10 years | - |
Gain YTD | 25.788 | 24.375 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 250 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 453M | 74.7B | 1% |
Annual Yield % from dividends | 1.32 | 0.93 | 142% |
Returns for 1 year | 4.51 | 15.38 | 29% |
Returns for 3 years | 17.88 | 57.29 | 31% |
Returns for 5 years | -16.86 | 29.08 | -58% |
Returns for 10 years | 15.47 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 67.02 | 0.80 | +1.21% |
ProShares Ultra Nasdaq Biotechnology | |||
JANW | 36.15 | 0.10 | +0.28% |
AllianzIM US Large Cap Buffer20 Jan ETF | |||
ENDW | 30.19 | N/A | +0.01% |
Cambria Endowment Style ETF | |||
XXCH | 32.39 | N/A | N/A |
Direxion Daily MSCI Em Mkt Ex Chn Bl 2X | |||
BBAG | 46.94 | -0.02 | -0.05% |
JPMorgan BetaBuilders US Aggt Bond ETF |